Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(2.78)
# 1,316
Out of 5,128 analysts
61
Total ratings
38.89%
Success rate
0.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TIL Instil Bio | Downgrades: Neutral | n/a | $7.00 | - | 4 | Jan 7, 2026 | |
| EVMN Evommune | Initiates: Buy | $35 | $18.05 | +93.96% | 1 | Jan 6, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Neutral | $55 → $60 | $60.60 | -0.99% | 3 | Dec 22, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $90 | $74.28 | +21.17% | 5 | Dec 19, 2025 | |
| ALMS Alumis | Maintains: Buy | $14 → $20 | $18.19 | +9.95% | 2 | Dec 18, 2025 | |
| LYEL Lyell Immunopharma | Upgrades: Buy | $20 → $45 | $25.23 | +78.36% | 2 | Dec 9, 2025 | |
| MGTX MeiraGTx Holdings | Initiates: Buy | $20 | $7.49 | +167.02% | 1 | Nov 24, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $40 → $30 | $7.70 | +289.61% | 1 | Nov 19, 2025 | |
| NGNE Neurogene | Maintains: Buy | $65 → $70 | $18.98 | +268.82% | 3 | Nov 13, 2025 | |
| KRRO Korro Bio | Downgrades: Neutral | n/a | $8.43 | - | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $4.24 | +135.85% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $15 | $10.53 | +42.45% | 5 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $110 | $83.32 | +32.02% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $8.73 | +129.10% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $26.75 | +49.53% | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $13 | $9.59 | +35.63% | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $40 | $18.91 | +111.53% | 6 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $60 | $22.20 | +170.27% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $56.69 | +41.12% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $17.01 | +46.97% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.08 | +140.38% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $10.70 | +133.64% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $5 | $23.93 | -79.11% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $29.52 | +1.63% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.79 | +291.06% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $5.21 | -61.61% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.28 | +212.50% | 1 | Aug 11, 2025 |
Instil Bio
Jan 7, 2026
Downgrades: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Evommune
Jan 6, 2026
Initiates: Buy
Price Target: $35
Current: $18.05
Upside: +93.96%
BioMarin Pharmaceutical
Dec 22, 2025
Maintains: Neutral
Price Target: $55 → $60
Current: $60.60
Upside: -0.99%
Halozyme Therapeutics
Dec 19, 2025
Reiterates: Buy
Price Target: $90
Current: $74.28
Upside: +21.17%
Alumis
Dec 18, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $18.19
Upside: +9.95%
Lyell Immunopharma
Dec 9, 2025
Upgrades: Buy
Price Target: $20 → $45
Current: $25.23
Upside: +78.36%
MeiraGTx Holdings
Nov 24, 2025
Initiates: Buy
Price Target: $20
Current: $7.49
Upside: +167.02%
Cartesian Therapeutics
Nov 19, 2025
Maintains: Buy
Price Target: $40 → $30
Current: $7.70
Upside: +289.61%
Neurogene
Nov 13, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $18.98
Upside: +268.82%
Korro Bio
Nov 13, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.43
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $4.24
Upside: +135.85%
Nov 10, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $10.53
Upside: +42.45%
Nov 10, 2025
Maintains: Buy
Price Target: $100 → $110
Current: $83.32
Upside: +32.02%
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $8.73
Upside: +129.10%
Oct 27, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $26.75
Upside: +49.53%
Oct 21, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $9.59
Upside: +35.63%
Oct 21, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $18.91
Upside: +111.53%
Oct 17, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $22.20
Upside: +170.27%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $56.69
Upside: +41.12%
Sep 17, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $17.01
Upside: +46.97%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.08
Upside: +140.38%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $10.70
Upside: +133.64%
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $23.93
Upside: -79.11%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $29.52
Upside: +1.63%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $1.79
Upside: +291.06%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $5.21
Upside: -61.61%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.28
Upside: +212.50%